This website uses tracking technologies, such as cookies, to provide a better user experience. If you continue to use this site, then you acknowledge our use of tracking technologies. For additional information, review our Privacy Policy.

Accept

The Cancer Research Institute Associate Board is a group of young leaders dedicated to advancing cancer immunotherapy research. Members lend professional expertise and diverse talents to develop social events, assist with fundraising initiatives, and cultivate individual and corporate relationships.

Chairman
Trent Kososki
Chairman
Members
Michael Arias
Board Member
Javier Artola
Board Member
Adler Bernard
Board Member
Michael Brown
Board Member
Ross Bruck
Board Member
Rada Cevher
Board Member
Morgan Cheatham
Board Member
Robert W. Chen
Board Member
Eash Cumarasamy
Board Member
Isabelle Franks
Board Member
Andrew Goldman
Board Member
Matt Goldman
Board Member
Jack Griffin
Board Member
Tj Gupta
Board Member
Courtney Shields Hassen
Board Member
Tyler Hassen
Board Member
Brooke James
Board Member
Samantha Knapik
Board Member
Jennifer Kososki
Board Member
Pär Lindstrom
Board Member
Drew Mallozzi
Board Member
Taylor Paul
Board Member
Tomas Peshkatari
Board Member
Vera Say
Board Member
Philip Shapiro
Board Member
Sam Shiverick
Board Member
Muhammad Siddiqui
Board Member
Christine Spencer
Board Member
Eddie Zhao
Board Member
Josh Tinch
Board Member
Let's spread the word about Immunotherapy! Click to share this page with your community.

*Immunotherapy results may vary from patient to patient.

Contact Us

Cancer Research Institute | National Headquarters
29 Broadway, Floor 4 | New York, NY 10006-3111

(800) 992-2623(212) 832-9376Staff Directory

Stay Connected with CRI

Follow us

Recent Blog Posts

Combined with chemotherapy, an HPV-targeting vaccine developed by CRI scientists led to encouraging responses in women with advanced cervical cancer.

Lessons learned from cancer immunotherapy research may help to curb the COVID-19 pandemic.
Top